2020 National Survey of Drug Use and Health (NSDUH) releases | CBHSQ data. https://www.samhsa.gov/data/release/2020-national-survey-drug-use-and-health-nsduh-releases. Accessed 9 May 2022.
Hoffman KA, Baker R, Kunkel LE, Waddell EN, Lum PJ, McCarty D, et al. Barriers and facilitators to recruitment and enrollment of HIV-infected individuals with opioid use disorder in a clinical trial. BMC Health Serv Res. 2019;19:862.
Article
PubMed
PubMed Central
Google Scholar
Patel K, Bunachita S, Agarwal AA, Lyon A, Patel UK. Opioid use disorder: treatments and barriers. Cureus. 2021;13: e13173.
PubMed
PubMed Central
Google Scholar
Mack KA, Jones CM, Ballesteros MF. Illicit drug use, illicit drug use disorders, and drug overdose deaths in metropolitan and nonmetropolitan areas—United States. MMWR Surveill Summ. 2017;66:1–12.
Article
PubMed
PubMed Central
Google Scholar
Grimm C. Geographic disparities affect access to buprenorphine services for opioid use disorder. US Department of Health and Human Services—Office of the Inspector General; 2020. https://oig.hhs.gov/oei/reports/oei-12-17-00240.pdf.
Results from the 2013 National Survey on Drug Use and Health: summary of national findings. 184.
Paulozzi LJ, Ryan GW. Opioid analgesics and rates of fatal drug poisoning in the United States. Am J Prev Med. 2006;31:506–11.
Article
PubMed
Google Scholar
Barnett PG. Comparison of costs and utilization among buprenorphine and methadone patients. Addiction. 2009;104:982–92.
Article
PubMed
Google Scholar
Antonacci DJ, Bloch RM, Saeed SA, Yildirim Y, Talley J. Empirical evidence on the use and effectiveness of telepsychiatry via videoconferencing: implications for forensic and correctional psychiatry. Behav Sci Law. 2008;26:253–69.
Article
PubMed
Google Scholar
Bai YM, Lin CC, Chen JY, Liu WC. Virtual psychiatric clinics. Am J Psychiatry. 2001;158:1160–1.
Article
CAS
PubMed
Google Scholar
Frueh BC, Henderson S, Myrick H. Telehealth service delivery for persons with alcoholism. J Telemed Telecare. 2005;11:372–5.
Article
PubMed
Google Scholar
Lange A, van de Ven JP, Schrieken BA, Bredeweg B, Emmelkamp PM. Internet-mediated, protocol-driven treatment of psychological dysfunction. J Telemed Telecare. 2000;6:15–21.
Article
CAS
PubMed
Google Scholar
Young LB. Telemedicine interventions for substance-use disorder: a literature review. J Telemed Telecare. 2012;18:47–53.
Article
PubMed
Google Scholar
Eibl JK, Gauthier G, Pellegrini D, Daiter J, Varenbut M, Hogenbirk JC, et al. The effectiveness of telemedicine-delivered opioid agonist therapy in a supervised clinical setting. Drug Alcohol Depend. 2017;176:133–8.
Article
PubMed
Google Scholar
Huskamp HA, Busch AB, Souza J, Uscher-Pines L, Rose S, Wilcock A, et al. How is telemedicine being used in opioid and other substance use disorder treatment? Health Aff (Millwood). 2018;37:1940–7.
Article
Google Scholar
Dennis BB, Naji L, Bawor M, Bonner A, Varenbut M, Daiter J, et al. The effectiveness of opioid substitution treatments for patients with opioid dependence: a systematic review and multiple treatment comparison protocol. Syst Rev. 2014;3:105.
Article
PubMed
PubMed Central
Google Scholar
Yang YT, Weintraub E, Haffajee RL. Telemedicine’s role in addressing the opioid epidemic. Mayo Clin Proc. 2018;93:1177–80.
Article
PubMed
Google Scholar
Weintraub E, Greenblatt AD, Chang J, Himelhoch S, Welsh C. Expanding access to buprenorphine treatment in rural areas with the use of telemedicine. Am J Addict. 2018;27:612–7.
Article
PubMed
Google Scholar
Zheng W, Nickasch M, Lander L, Wen S, Xiao M, Marshalek P, et al. Treatment outcome comparison between telepsychiatry and face-to-face buprenorphine medication-assisted treatment for opioid use disorder: a 2-year retrospective data analysis. J Addict Med. 2017;11:138–44.
Article
CAS
PubMed
PubMed Central
Google Scholar
Weintraub E, Greenblatt AD, Chang J, Welsh CJ, Berthiaume AP, Goodwin SR, et al. Outcomes for patients receiving telemedicine-delivered medication-based treatment for opioid use disorder: a retrospective chart review. Heroin Addict Relat Clin Probl. 2021;23:5–12.
PubMed
PubMed Central
Google Scholar
Brunet N, Moore DT, LendvaiWischik D, Mattocks KM, Rosen MI. Increasing buprenorphine access for veterans with opioid use disorder in rural clinics using telemedicine. Subst Abus. 2020;43:1–8.
Google Scholar
Uscher-Pines L, Raja P, Mehrotra A, Huskamp HA. Health center implementation of telemedicine for opioid use disorders: a qualitative assessment of adopters and nonadopters. J Subst Abuse Treat. 2020;115: 108037.
Article
PubMed
PubMed Central
Google Scholar
Huskamp HA, Riedel L, Uscher-Pines L, Busch AB, Barnett ML, Raja P, et al. Initiating opioid use disorder medication via telemedicine during COVID-19: implications for proposed reforms to the ryan haight act. J Gen Intern Med. 2022;37:162–7.
Article
PubMed
Google Scholar
Waselewski ME, Flickinger TE, Canan C, Harrington W, Franklin T, Otero KN, et al. A mobile health app to support patients receiving medication-assisted treatment for opioid use disorder: development and feasibility study. JMIR Form Res. 2021;5: e24561.
Article
PubMed
PubMed Central
Google Scholar
Statement of regulatory priorities for fiscal year 2022. US Department of Health and Human Services; 2021. https://www.reginfo.gov/public/jsp/eAgenda/StaticContent/202110/Statement_0900_HHS.pdf.
Ozga JE, Paquette C, Syvertsen JL, Pollini RA. Mobile phone and internet use among people who inject drugs: implications for mobile health interventions. Subst Abus. 2022;43:592–7.
Article
PubMed
Google Scholar
Sugarman DE, Busch AB, McHugh RK, Bogunovic OJ, Trinh CD, Weiss RD, et al. Patients’ perceptions of telehealth services for outpatient treatment of substance use disorders during the COVID-19 pandemic. Am J Addict. 2021;30:445–52.
Article
PubMed
PubMed Central
Google Scholar
Mackay L, Kerr T, Fairbairn N, Grant C, Milloy M-J, Hayashi K. The relationship between opioid agonist therapy satisfaction and fentanyl exposure in a Canadian setting. Addict Sci Clin Pract. 2021;16:26.
Article
PubMed
PubMed Central
Google Scholar
Lin LA, Casteel D, Shigekawa E, Weyrich MS, Roby DH, McMenamin SB. Telemedicine-delivered treatment interventions for substance use disorders: a systematic review. J Subst Abuse Treat. 2019;101:38–49.
Article
PubMed
Google Scholar
Marsden J, Ogborne A, Farrell M, Rush B, Team WHOM of SD, Programme UNIDC, et al. International guidelines for the evaluation of treatment services and systems for psychoactive substance use disorders. World Health Organization; 2000. Report No. WHO/MSD/MSB/00.5. https://apps.who.int/iris/handle/10665/66633.
McCurdie T, Taneva S, Casselman M, Yeung M, McDaniel C, Ho W, et al. mHealth consumer apps: the case for user-centered design. Biomed Instrum Technol. 2012;46(Suppl 2):49–56.
Article
Google Scholar
Center for Drug Evaluation and Research. The voice of the patient. U.S. Food and Drug Administration; 2018. https://www.fda.gov/media/124391/download.
Davis FD. Perceived usefulness, perceived ease of use, and user acceptance of information technology. MIS Q. 1989;13:319–40.
Article
Google Scholar
Salazar ZR, Vincent L, Figgatt MC, Gilbert MK, Dasgupta N. Research led by people who use drugs: centering the expertise of lived experience. Subst Abus Treat Prev Policy. 2021;16:70.
Article
Google Scholar
International Standards for the Treatment of Drug Use Disorders. https://www.who.int/publications-detail-redirect/international-standards-for-the-treatment-of-drug-use-disorders. Accessed 10 May 2022.
Abuse NI on D. Small business innovation research (SBIR) and technology transfer (STTR) programs. National Institute on Drug Abuse. 2022 https://nida.nih.gov/funding/small-business-innovation-research-sbir-technology-transfer-sttr-programs. Accessed 9 May 2022.
Maguire M. Methods to support human-centred design. Int J Hum Comput Stud. 2001;55:587–634.
Article
Google Scholar
Lobe B, Morgan D, Hoffman KA. Qualitative data collection in an era of social distancing. Int J Qual Methods. 2020;19:1609406920937875.
Article
Google Scholar
Haniff D. Usability engineering and e-health. Human-centered design of e-health technologies: concepts, methods and applications. IGI Global; 2011. p. 41–64. https://www.igi-global.com/chapter/usability-engineering-health/www.igi-global.com/chapter/usability-engineering-health/50780. Accessed 9 May 2022.
Watkins DC. Rapid and rigorous qualitative data analysis: the “RADaR” technique for applied research. Int J Qual Methods. 2017;16:1609406917712131.
Article
Google Scholar
ClinCard—industry leading participant payment automation—Greenphire. greenphire.com. https://greenphire.com/participant-payments/. Accessed 9 May 2022.
Glass JE, Matson TE, Lim C, Hartzler AL, Kimbel K, Lee AK, et al. Approaches for implementing app-based digital treatments for drug use disorders into primary care: a qualitative, user-centered design study of patient perspectives. J Med Internet Res. 2021;23: e25866.
Article
PubMed
PubMed Central
Google Scholar
Gryczynski J, Mitchell SG, Jaffe JH, O’Grady KE, Olsen YK, Schwartz RP. Leaving buprenorphine treatment: patients’ reasons for cessation of care. J Subst Abus Treat. 2014;46:356–61.
Article
Google Scholar
Lynch AC, Weber AN, Hedden S, Sabbagh S, Arndt S, Acion L. Three-month outcomes from a patient-centered program to treat opioid use disorder in Iowa, USA. Subst Abus Treat Prev Policy. 2021;16:8.
Article
Google Scholar
Lockard R, Priest KC, Gregg J, Buchheit BM. A qualitative study of patient experiences with telemedicine opioid use disorder treatment during COVID-19. Subst Abus. 2022;43:1150–7.
Article
PubMed
Google Scholar
Levander XA, Pytell JD, Stoller KB, Korthuis PT, Chander G. COVID-19-related policy changes for methadone take-home dosing: a multistate survey of opioid treatment program leadership. Subst Abus. 2022;43:633–9.
Article
PubMed
Google Scholar
White WL. Peer-based Addiction Recovery Support: History, Theory, Practice, and Scientific Evaluation. 2009. http://www.williamwhitepapers.com/pr/2009Peer-10.1186/s13722-022-00331-4BasedRecoverySupportServices.pdf. Accessed 17 Jan 2022.
Bassuk EL, Hanson J, Greene RN, Richard M, Laudet A. Peer-delivered recovery support services for addictions in the United States: a systematic review. J Subst Abus Treat. 2016;63:1–9.
Article
Google Scholar
Kleinman MB, Felton JW, Johnson A, Magidson JF. “I have to be around people that are doing what I’m doing”: the importance of expanding the peer recovery coach role in treatment of opioid use disorder in the face of COVID-19 health disparities. J Subst Abuse Treat. 2021;122: 108182.
Article
CAS
PubMed
Google Scholar
Hooker SA, Sherman MD, Lonergan-Cullum M, Sattler A, Liese BS, Justesen K, et al. Mental health and psychosocial needs of patients being treated for opioid use disorder in a primary care residency clinic. J Prim Care Community Health. 2020;11:2150132720932017.
Article
PubMed
PubMed Central
Google Scholar
Opioid overdose deaths by race/ethnicity. KFF. 2022. https://www.kff.org/other/state-indicator/opioid-overdose-deaths-by-raceethnicity/. Accessed 9 May 2022.
McHugh RK. The importance of studying sex and gender differences in opioid misuse. JAMA Netw Open. 2020;3: e2030676.
Article
PubMed
Google Scholar
Moore DJ, Goyal D, Rodriguez L. Experiences of opioid use disorder patients receiving buprenorphine through a telehealth program. J Addict Nurs. 2021;32:205–10.
Article
PubMed
Google Scholar